Literature DB >> 15090194

High throughput screening technologies for direct cyclic AMP measurement.

Daniela Gabriel1, Magali Vernier, Martin J Pfeifer, Boris Dasen, Laurent Tenaillon, Rochdi Bouhelal.   

Abstract

A study comparing five different cAMP detection technologies in terms of sensitivity, robustness, and feasibility for HTS is presented. In this report, the following methods are described: a nonhomogeneous DELFIA, and the homogeneous methods based on time-resolved fluorescence (HTRF), luminescent singlet oxygen channeling or ALPHAScreen, FP, and high-affinity enzyme complementation. DELFIA had the highest sensitivity, whereas ALPHAScreen and HTRF shared several advantages, including high sensitivity, broad dynamic range, and minimal reagent addition steps. For G(s)-coupled antagonist screens, we found HTRF and ALPHAScreen the more sensitive and HTS-compatible techniques.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15090194     DOI: 10.1089/15406580360545107

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  24 in total

Review 1.  Design and implementation of high throughput screening assays.

Authors:  Ricardo Macarrón; Robert P Hertzberg
Journal:  Mol Biotechnol       Date:  2011-03       Impact factor: 2.695

2.  Dynamic Coupling and Allosteric Networks in the α Subunit of Heterotrimeric G Proteins.

Authors:  Xin-Qiu Yao; Rabia U Malik; Nicholas W Griggs; Lars Skjærven; John R Traynor; Sivaraj Sivaramakrishnan; Barry J Grant
Journal:  J Biol Chem       Date:  2015-12-24       Impact factor: 5.157

Review 3.  Heterotrimeric G proteins and the single-transmembrane domain IGF-II/M6P receptor: functional interaction and relevance to cell signaling.

Authors:  C Hawkes; A Amritraj; R G Macdonald; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

Review 4.  Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies.

Authors:  Stephen J Hill; Christine Williams; Lauren T May
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

5.  Identification of raloxifene as a novel CB2 inverse agonist.

Authors:  Pritesh Kumar; Zhao-Hui Song
Journal:  Biochem Biophys Res Commun       Date:  2013-04-20       Impact factor: 3.575

6.  Comparison on functional assays for Gq-coupled GPCRs by measuring inositol monophospate-1 and intracellular calcium in 1536-well plate format.

Authors:  Ke Liu; Steve Titus; Noel Southall; Pingjun Zhu; James Inglese; Christopher P Austin; Wei Zheng
Journal:  Curr Chem Genomics       Date:  2008-07-11

7.  The use of AlphaScreen technology in HTS: current status.

Authors:  Richard M Eglen; Terry Reisine; Philippe Roby; Nathalie Rouleau; Chantal Illy; Roger Bossé; Martina Bielefeld
Journal:  Curr Chem Genomics       Date:  2008-02-25

8.  Cellular Ser/Thr-kinase assays using generic peptide substrates.

Authors:  Deanna G Adams; Yu Wang; Puiying A Mak; Jason Chyba; Orzala Shalizi; Jason Matzen; Paul Anderson; Tim R Smith; Michael Garcia; Genevieve L Welch; Emmanuel J Claret; Michel Fink; Anthony P Orth; Jeremy S Caldwell; Achim Brinker
Journal:  Curr Chem Genomics       Date:  2008-05-23

9.  Identification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay.

Authors:  Catherine Z Chen; Noel Southall; Jingbo Xiao; Juan J Marugan; Marc Ferrer; Xin Hu; Raisa E Jones; Shu Feng; Irina U Agoulnik; Wei Zheng; Alexander I Agoulnik
Journal:  J Biomol Screen       Date:  2012-12-04

10.  Quantitative high-throughput screening using a live-cell cAMP assay identifies small-molecule agonists of the TSH receptor.

Authors:  Steve Titus; Susanne Neumann; Wei Zheng; Noel Southall; Sam Michael; Carleen Klumpp; Adam Yasgar; Paul Shinn; Craig J Thomas; James Inglese; Marvin C Gershengorn; Christopher P Austin
Journal:  J Biomol Screen       Date:  2008-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.